The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP-Reference-Cited by-同舟云学术

The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP

Published:2017-10-19 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Wei Xiaolei,Hao Xiaoxiao,Zhou Lizhi,Wei Qi,Zhang Yuankun,Huang Weimin,Song Jialin,Feng Ru,Wei Yongqiang

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-13254-x.pdf

Reference26 articles.

1. Swerdlow, S. H., Campo, E. & Harris, N. L. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (4th Ed). Lyon, France: IARC (2008).

2. Coiffier, B. et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. The New England journal of medicine 346, 235–242, https://doi.org/10.1056/NEJMoa011795 (2002).

3. Habermann, T. M. et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 24, 3121–3127, https://doi.org/10.1200/jco.2005.05.1003 (2006).

4. Pfreundschuh, M. et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. The Lancet. Oncology 7, 379–391, https://doi.org/10.1016/s1470-2045(06)70664-7 (2006).

5. Coiffier, B. & Sarkozy, C. Diffuse large B-cell lymphoma: R-CHOP failure-what to do? Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2016, 366–378, https://doi.org/10.1182/asheducation-2016.1.366 (2016).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of next-generation sequencing in diffuse large B-cell lymphoma;Pharmacogenomics;2023-01

2. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel prognostic factor for patients with diffuse large B-cell lymphoma;Journal of Cancer Research and Therapeutics;2022

3. Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma;International Journal of Hematology;2020-01-28

4. Publisher Correction: The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP;Scientific Reports;2019-05-03

5. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database;Pathology - Research and Practice;2018-11